Botanical species · safety record

Alpinia galanga

The EFSA Compendium of Botanicals holds 35 constituent measurements and 1 adverse-effect record for Alpinia galanga. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Alpinia galanga (L.) Willd.

35Constituent measurements

1Safety records

9Cited sources

57Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 57 licensed products naming Alpinia galanga as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Dried root(s)
Rhizome
Rhizome Extract
Rhizome(s)
Root

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Leaves	Essential oil	≤ 26.3 Percent	GC-MS	Resolve DOI
1,8-cineole	Roots and other underground parts	Essential oil	≤ 42.3 Percent	GC-MS	Resolve DOI
1,8-cineole	Roots and other underground parts	Essential oil	≥ 6.1 Percent	GC-MS	Resolve DOI
1,8-cineole	Leaves	Essential oil	≥ 23 Percent	GC-MS	Resolve DOI
1,8-cineole	Flower	Essential oil	≤ 18.4 Percent	GC-MS	Resolve DOI
1,8-cineole	Flower	Essential oil	≥ 9.4 Percent	GC-MS	Resolve DOI
1,8-cineole	Roots and other underground parts used as staple food	Essential oil	63.4 Percent	GC-FID	Resolve DOI
Camphor	Leaves	Essential oil	≥ 10.7 Percent	GC-MS	Resolve DOI
Camphor	Roots and other underground parts	Essential oil	≤ 3.2 Percent	GC-MS	Resolve DOI
Camphor	Roots and other underground parts	Essential oil	≥ 0.7 Percent	GC-MS	Resolve DOI
Camphor	Leaves	Essential oil	≤ 23 Percent	GC-MS	Resolve DOI
Camphor	Flower	Essential oil	≤ 2.9 Percent	GC-MS	Resolve DOI
Camphor	Flower	Essential oil	≥ 1.5 Percent	GC-MS	Resolve DOI
Costunolide	Roots and other underground parts	—	—	Unspecified	Resolve DOI
Myrcene	Leaves	Essential oil	≤ 1.3 Percent	GC-MS	Resolve DOI
Myrcene	Leaves	Essential oil	≥ 0.3 Percent	GC-MS	Resolve DOI
Myrcene	Flower	Essential oil	≤ 1.1 Percent	GC-MS	Resolve DOI
Myrcene	Flower	Essential oil	≥ 1 Percent	GC-MS	Resolve DOI
Neolignans	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Phenylpropanoids	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
1,8-cineole	Leaves	Essential oil	28.34 Percent	GC-FID-MS	No resolvable identifier
1,8-cineole	Stem / stalk	Essential oil	31.12 Percent	GC-FID-MS	No resolvable identifier
1,8-cineole	Roots and other underground parts	Solvent extraction	39.4 Percent	GC-MS	No resolvable identifier
1,8-cineole	Roots and other underground parts	Essential oil	≤ 28.42 Percent	GC-FID-MS	No resolvable identifier
1,8-cineole	Roots and other underground parts	Essential oil	≥ 9.44 Percent	GC-FID-MS	No resolvable identifier
Camphor	Stem / stalk	Essential oil	11.01 Percent	GC-FID-MS	No resolvable identifier
Camphor	Roots and other underground parts	Solvent extraction	3.8 Percent	GC-MS	No resolvable identifier
Camphor	Roots and other underground parts	Essential oil	≤ 7.71 Percent	GC-FID-MS	No resolvable identifier
Camphor	Roots and other underground parts	Essential oil	≥ 1.24 Percent	GC-FID-MS	No resolvable identifier
Camphor	Leaves	Essential oil	15.59 Percent	GC-FID-MS	No resolvable identifier
Fenchone	Roots and other underground parts	Essential oil	1.16 Percent	GC-FID-MS	No resolvable identifier
Methyleugenol	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Myrcene	Roots and other underground parts	Essential oil	1.8 Percent	GC-FID-MS	No resolvable identifier
Naphthalene	Roots and other underground parts	Solvent extraction	1.65 Percent Area	GC-MS	No resolvable identifier
P-coumaric acid	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Hemopoietic	Cardiovascular / haematological	Roots and other underground parts	Solvent extraction	House mouse (as animal)	Subchronic	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Padalia, Rajendra C., Verma, Ram S., Sundaresan, Velusamy., Chanotiya, Chandan S. Chemical Diversity in the Genus Alpinia (Zingiberaceae): Comparative Composition of Four Alpinia Species Grown in Northern India. CHEMISTRY & BIODIVERSITY, 2010, vol. 7, no. 8, p. 2076-2087. DOI
Zhao Ling., Chen Lv-Yi., Liang Jing-Yu. Two new phenylpropanoids isolated from the rhizomes of Alpinia galanga. Chinese journal of natural medicines, 2012, vol. 10, no. 5, p. 370-373. DOI
Kaur, Amandeep., Singh, Ranvir., eyb, Chinmoy Sankar., Sharma, Shyam Sundar., Bhutani, Kamlesh K., Singh, Inder Pal. Antileishmanial phenylpropanoids from Alpinia galanga (Linn.) Willd.. Indian journal of experimental biology, 2010, vol. 48, no. 3, p. 314-317.
Morikawa, T., Ando, S., Matsuda, H., Kataoka, S., Muraoka, O., Yoshikawa, M. Inhibitors of nitric oxide production from the rhizomes of Alpinia galanga: Structures of new 8-9 ' linked neolignans and sesquineolignan . Chemical & pharmaceutical bulletin, 2005, vol. 53, no. 6, p. 625-630. DOI
Das, A., Santhy, K.S. Chemical characterisation of Alpinia Galanga (L.) willd by GC-MS, XRD, FTIR and UV-VIS spectroscopic methods. International journal of pharmacy and pharmaceutical sciences, 2015, vol. 7, no. 9, p. 499-501.
Jirovetz, Leopold., Buchbauer, Gerhard., Shafi, Mohamed Pottachola., Leela, Neettiyath Kalathil. Analysis of the essential oils of the leaves, stems, rhizomes and roots of the medicinal plant Alpinia galanga from southern India. . Acta pharmaceutica (zagreb), 2003, vol. 53, no. 2, p. 73-81.
Ando, S., Matsuda, H., Morikawa, T., Yoshikawa, M. 1'S-1'-acetoxychavicol acetate as a new type inhibitor of interferon-beta production in lipopolysaccharide-activated mouse peritoneal macrophages . Bioorganic & medicinal chemistry, 2005, vol. 13, no. 9, p. 3289-3294. DOI
QURESHI, S., SHAH, AH., AGEEL, AM. TOXICITY STUDIES ON ALPINIA-GALANGA AND CURCUMA-LONGA. Planta medica, 1992, vol. 58, no. 2, p. 124-127. DOI
Raina, Archana P., Verma, S. K., Abraham, Z. Volatile constituents of essential oils isolated from Alpinia galanga Willd. (L.) and A. officinarum Hance rhizomes from North East India . Journal of essential oil research, 2014, vol. 26, no. 1, p. 24-28. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature